Genomic and proteomic profiling I: leiomyomas in African Americans and Caucasians.
BACKGROUND
Clinical observations indicate that leiomyomas occur more frequently in African Americans compared to other ethnic groups with unknown etiology. To identify the molecular basis for the difference we compared leiomyomas form A. Americans with Caucasians using genomic and proteomic strategies.


METHODS
Microarray, realtime PCR, 2D-PAGE, mass spectrometry, Western blotting and immunohistochemistry.


RESULTS
Using Affymetrix U133A array and analysis based on P ranking (P < 0.01) 1470 genes were identified as differentially expressed in leiomyomas compared to myometrium regardless of ethnicity. Of these, 268 genes were either over-expressed (177 genes) or under-expressed (91 genes) based on P < 0.01 followed by 2-fold cutoff selection in leiomyomas of A. Americans as compared to Caucasians. Among them, the expression E2F1, RUNX3, EGR3, TBPIP, ECM2, ESM1, THBS1, GAS1, ADAM17, CST6, CST7, FBLN5, ICAM2, EDN1 and COL18 was validated using realtime PCR low-density arrays. 2D PAGE coupled with image analysis identified 332 protein spots of which the density/volume of 31 varied by greater than or equal to 1.5 fold in leiomyomas as compared to myometrium. The density/volume of 34 protein-spots varied by greater than or equal to 1.5 fold (26 increased and 8 decreased) in leiomyomas of A. Americans as compared to Caucasians. Tandem mass spectrometric analysis of 15 protein spots identified several proteins whose transcripts were also identified by microarray, including 14-3-3 beta and mimecan, whose expression was confirmed using western blotting and immunohistochemistry.


CONCLUSIONS
These findings imply that the level rather than the ethnic-specific expression of a number of genes and proteins may account for the difference between leiomyomas and possibly myometrium, in A. Americans and Caucasians. Further study using larger sample size is required to confirm these findings.
Pan
Qun
Q
Department of Obstetrics and Gynecology, University of Florida, Gainesville, Florida 32610, USA. panq@obgyn.ufl.edu
Luo
Xiaoping
X
Chegini
Nasser
N
D000328:Adult; D001741:Black or African American / Q000235:genetics*; D005260:Female; D020869:Gene Expression Profiling / Q000379:methods; D023281:Genomics / Q000379:methods; D006801:Humans; D007889:Leiomyoma / Q000235:genetics* / Q000473:pathology; D040901:Proteomics / Q000379:methods; D014594:Uterine Neoplasms / Q000235:genetics* / Q000473:pathology; D044465:White People / Q000235:genetics*
J Clin Endocrinol Metab. 2003 Mar;88(3):1350-61
12629129
Genomics. 1998 Sep 15;52(3):378-81
9790758
EMBO J. 2003 May 15;22(10):2453-62
12743039
DNA Cell Biol. 2004 Jan;23(1):25-34
14965470
Genes Chromosomes Cancer. 2004 Jun;40(2):97-108
15101043
J Histochem Cytochem. 2004 Jun;52(6):735-48
15150282
J Exp Med. 2004 Aug 2;200(3):377-89
15289506
Crit Rev Clin Lab Sci. 2004;41(3):233-64
15307633
Environ Health Perspect. 2003 Jun;111(8):1037-54
12826476
Mol Vis. 2003 Jun 30;9:277-87
12835654
Fertil Steril. 2003 Aug;80(2):266-76
12909484
J Biol Chem. 2003 Sep 12;278(37):35444-50
12824180
Mol Hum Reprod. 2003 Nov;9(11):709-17
14561813
Mol Cell Endocrinol. 2003 Nov 14;209(1-2):9-16
14604812
Cell Cycle. 2004 Jan;3(1):10-1
14657654
Am J Epidemiol. 2004 Jan 15;159(2):113-23
14718211
Int J Exp Pathol. 2003 Dec;84(6):267-79
14748746
Eur J Immunol. 1999 Mar;29(3):1004-13
10092105
J Cell Physiol. 1999 Jul;180(1):61-70
10362018
J Clin Endocrinol Metab. 2004 Nov;89(11):5549-57
15531510
J Biol Chem. 2005 Feb 18;280(7):5812-9
15574415
Endocrinology. 2005 Mar;146(3):1074-96
15604208
Endocrinology. 2005 Mar;146(3):1097-118
15604209
Obstet Gynecol. 2005 Mar;105(3):563-8
15738025
Mol Hum Reprod. 2005 Jul;11(7):489-94
16123076
Hum Reprod. 2006 Jan;21(1):57-67
16172143
J Clin Endocrinol Metab. 2005 Dec;90(12):6657-64
16189248
Biochim Biophys Acta. 2006 Jan;1765(1):25-37
16168566
J Soc Gynecol Investig. 2006 Feb;13(2):136-44
16443508
Cancer Res. 2006 Mar 1;66(5):2621-9
16510581
Fertil Steril. 2006 Feb;85(2):462-7
16595228
J Cell Biochem. 2006 May 15;98(2):383-93
16440305
Mol Hum Reprod. 2006 Mar;12(3):187-207
16524927
Mol Hum Reprod. 2006 Apr;12(4):245-56
16571622
Semin Cancer Biol. 2006 Jun;16(3):203-13
16725345
Dev Cell. 2006 Jul;11(1):93-104
16824956
Gynecol Oncol. 2006 Oct;103(1):186-9
16595146
Steroids. 2006 Nov;71(11-12):960-5
16935316
J Cell Sci. 2006 Nov 1;119(Pt 21):4499-509
17046999
Mol Hum Reprod. 2007 May;13(5):343-9
17360930
Reprod Biol Endocrinol. 2007;5:35
17718906
Annu Rev Pharmacol Toxicol. 2000;40:617-47
10836149
J Biol Chem. 2000 Dec 15;275(50):39039-47
10982796
Hum Reprod Update. 2001 Jan-Feb;7(1):8-14
11212080
J Biol Chem. 2001 Nov 2;276(44):41318-24
11533041
Mol Hum Reprod. 2002 Mar;8(3):246-54
11870232
Fertil Steril. 2002 Jul;78(1):114-21
12095500
J Cell Physiol. 2002 Dec;193(3):287-92
12384981
Mol Hum Reprod. 2002 Dec;8(12):1071-8
12468639
Mol Hum Reprod. 2004 Oct;10(10):735-42
15322223
Mol Vis. 2004 Oct 7;10:758-72
15496828
Cell. 1998 Jun 26;93(7):1159-70
9657149
J Soc Gynecol Investig. 2003 Apr;10(3):161-71
12699880